Heidelberg, Germany, Gembloux, Belgium, and Shanghai, China — December 19, 2024 — Full-Life Technologies, a clinical-stage, fully integrated global radiotherapeutics company, today announced that Julie Wu, President & Chief Financial Officer, Dr. Fa Liu, Chief Scientific Officer and Oliver Froescheis, Senior Vice President of Corporate Development will participate in the 43rd Annual J.P. Morgan Healthcare Conference being held January 13-16, 2025 in San Francisco, California, USA, and host meetings.

About Full-Life Technologies

Full-Life Technologies ("Full-Life") is a clinical-stage, fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China. We aim to own the entire value chain for radiopharmaceutical research & development, production & commercialization to deliver clinical impact for patients. The Company endeavors to tackle fundamental challenges affecting radiopharmaceuticals today by pioneering innovative research that will shape the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and seasoned scientists with a proven history of success in the life sciences, alongside radioisotope research and clinical development.